sopharma - Najnowsze wiadomości
2026-04-03 08:42SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_117_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-04-02 08:36SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_116_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-31 08:35SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_115_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-30 10:08SOPHARMA AD: Publishing of Annual individual audited financial statement for 2025Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:097900BGGW0000048796-20251231-EN-SEP.rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2026-03-30 08:37SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_113_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-27 08:44SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_112_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-26 08:35SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_111_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-25 08:38SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_110_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-24 08:45SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_109_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-23 08:45SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_108_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-20 14:19SOPHARMA AD: Notification for sales revenues for February 2026Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_Sales_Revenues_February_2026_EN_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-20 08:13SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_106_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-19 08:31SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_105_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2026-03-18 09:34SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_104_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...- 2026-03-11 10:49SOPHARMA AD: Notification from "Donev investments holding" under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev investments holding_Sopharma_EN_warrant7_2026.03.09.pdf td.td-text, th.td-text { word-break: keep-all;...
- 2026-03-10 15:04SOPHARMA AD: Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Telso AD_Sopharma_warrants_7years_EN_09.03.2026.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
- 2026-03-09 12:47SOPHARMA AD: Notification from Ognian Donev under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200003259Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:ODonev_Sopharma_warrants_7years_EN_09032026.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
- 2026-03-06 14:56SOPHARMA AD: Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200004257Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Telso AD_Sopharma_warrants_5years_EN_05.03.2026.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
- 2026-03-06 14:50SOPHARMA AD: Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN № BG9200001253Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Telso AD_Sopharma_warrants_3years_EN_04.03.2026.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...